1 |
|
Metabolism of nucleotides
|
99 |
2.329 |
Genes names |
- Adenosine Deaminase
- Adenosine Deaminase Like
- Adenosine Kinase
- Adenosine Monophosphate Deaminase 1
- Adenosine Monophosphate Deaminase 2
- Adenosine Monophosphate Deaminase 3
|
Pathways |
- adenosine ribonucleotides de novo biosynthesis
- superpathway of adenosine nucleotides de novo biosynthesis I
- adenosine nucleotides degradation II
- adenosine nucleotides degradation
|
|
2 |
|
Nucleotide salvage
|
23 |
1.697 |
Genes names |
- Adenosine Deaminase
- Adenosine Deaminase Like
- Adenosine Kinase
- Adenosine Monophosphate Deaminase 1
- Adenosine Monophosphate Deaminase 2
- Adenosine Monophosphate Deaminase 3
|
Pathways |
- adenine and adenosine salvage III
|
|
3 |
|
Purinergic signaling
|
35 |
1.502 |
Genes names |
- Adenosine A1 Receptor
- Adenosine A2a Receptor
- Adenosine A2b Receptor
- Adenosine A3 Receptor
|
Pathways |
|
|
4 |
|
Formation of editosomes by ADAR proteins
|
2 |
1.247 |
Genes names |
- Adenosine Deaminase RNA Specific
- Adenosine Deaminase RNA Specific B1
|
Pathways |
- C6 deamination of adenosine
|
|
5 |
|
ATP/ITP metabolism
|
85 |
1.231 |
Genes names |
- Adenosine Deaminase
- Adenosine Deaminase RNA Specific
- Adenosine Deaminase RNA Specific B1
- Adenosine Deaminase RNA Specific B2 (Inactive)
- Adenosine Kinase
- Adenosine Monophosphate Deaminase 1
- Adenosine Monophosphate Deaminase 2
- Adenosine Monophosphate Deaminase 3
|
|
6 |
|
Processing of Capped Intron-Containing Pre-mRNA
|
745 |
1.151 |
Genes names |
- Adenosine Deaminase RNA Specific
- Adenosine Deaminase RNA Specific B1
- Adenosine Deaminase TRNA Specific 1
- Adenosine Deaminase TRNA Specific 2
- Adenosine Deaminase TRNA Specific 3
- Methyltransferase 14, N6-Adenosine-Methyltransferase Subunit
- Methyltransferase 3, N6-Adenosine-Methyltransferase Complex Catalytic Subunit
|
|
7 |
|
Remdesivir Pathway, Pharmacokinetics
|
9 |
1.067 |
Genes names |
|
Pathways |
- adenine and adenosine salvage VI
|
|
8 |
|
purine deoxyribonucleosides degradation II
|
3 |
1.067 |
Genes names |
|
Pathways |
- Defective ADA disrupts (deoxy)adenosine deamination
|
|
9 |
|
Metabolism
|
2121 |
1.066 |
Genes names |
- Adenosine Deaminase
- Adenosine Deaminase Like
- Adenosine Kinase
- Adenosine Monophosphate Deaminase 1
- Adenosine Monophosphate Deaminase 2
- Adenosine Monophosphate Deaminase 3
|
|
10 |
|
GPCR downstream signalling
|
710 |
0.870 |
Genes names |
- Adenosine A1 Receptor
- Adenosine A2a Receptor
- Adenosine A2b Receptor
- Adenosine A3 Receptor
|
|
11 |
|
Class A/1 (Rhodopsin-like receptors)
|
556 |
0.870 |
Genes names |
- Adenosine A1 Receptor
- Adenosine A2a Receptor
- Adenosine A2b Receptor
- Adenosine A3 Receptor
|
|
12 |
|
Signal Transduction
|
2590 |
0.870 |
Genes names |
- Adenosine A1 Receptor
- Adenosine A2a Receptor
- Adenosine A2b Receptor
- Adenosine A3 Receptor
|
|
13 |
|
tRNA processing
|
107 |
0.754 |
Genes names |
- Adenosine Deaminase TRNA Specific 1
- Adenosine Deaminase TRNA Specific 2
- Adenosine Deaminase TRNA Specific 3
|
|
14 |
|
Drug ADME
|
122 |
0.754 |
Genes names |
- Adenosine Deaminase
- Adenosine Deaminase Like
- Adenosine Kinase
|
|
15 |
|
Development Angiotensin activation of ERK
|
225 |
0.754 |
Genes names |
- Adenosine A2a Receptor
- Adenosine A2b Receptor
- Adenosine A3 Receptor
|
|
16 |
|
Metabolism of proteins
|
1970 |
0.754 |
Genes names |
- Adenosine Deaminase 2
- Adenosine A2a Receptor
- Adenosine A2b Receptor
|
|
17 |
|
Surfactant metabolism
|
29 |
0.754 |
Genes names |
- Adenosine Deaminase 2
- Adenosine A2a Receptor
- Adenosine A2b Receptor
|
|
18 |
|
Innate Immune System
|
2025 |
0.754 |
Genes names |
- Adenosine Deaminase 2
- Adenosine Deaminase RNA Specific
- Adenosine Monophosphate Deaminase 3
|
|
19 |
|
pyrimidine deoxyribonucleotides biosynthesis from CTP
|
16 |
0.632 |
Pathways |
- adenosine deoxyribonucleotides de novo biosynthesis
|
|
20 |
|
Formation of the Editosome
|
11 |
0.615 |
Genes names |
- Adenosine Deaminase RNA Specific
- Adenosine Deaminase RNA Specific B1
|
|
21 |
|
Development A3 receptor signaling
|
106 |
0.615 |
Genes names |
- Adenosine A1 Receptor
- Adenosine A3 Receptor
|
|
22 |
|
GPCRs, other
|
100 |
0.615 |
Genes names |
- Adenosine A2a Receptor
- Adenosine A3 Receptor
|
|
23 |
|
Chromatin Regulation / Acetylation
|
255 |
0.615 |
Genes names |
- Methyltransferase 14, N6-Adenosine-Methyltransferase Subunit
- Methyltransferase 3, N6-Adenosine-Methyltransferase Complex Catalytic Subunit
|
|
24 |
|
Development A2B receptor- action via G-protein alpha s
|
87 |
0.615 |
Genes names |
- Adenosine A2a Receptor
- Adenosine A2b Receptor
|
|
25 |
|
Infectious disease
|
1747 |
0.615 |
Genes names |
- Adenosine Deaminase
- Adenosine A2b Receptor
|
|
26 |
|
C-MYB transcription factor network
|
80 |
0.615 |
Genes names |
- Adenosine Deaminase
- Adenosine A2b Receptor
|
|
27 |
|
Purine metabolism and related disorders
|
23 |
0.615 |
Genes names |
- Adenosine Deaminase
- Adenosine Monophosphate Deaminase 1
|
|
28 |
|
G alpha (s) signalling events
|
158 |
0.615 |
Genes names |
- Adenosine A2a Receptor
- Adenosine A2b Receptor
|
|
29 |
|
Beta-Adrenergic Signaling
|
333 |
0.435 |
|
30 |
|
Pathways of nucleic acid metabolism and innate immune sensing
|
16 |
0.435 |
Genes names |
- Adenosine Deaminase RNA Specific
|
|
31 |
|
Cannabinoid receptor signaling
|
20 |
0.435 |
|
32 |
|
HIF-2-alpha transcription factor network
|
30 |
0.435 |
|
33 |
|
Monoamine transport
|
33 |
0.435 |
|
34 |
|
p73 transcription factor network
|
76 |
0.435 |
|
35 |
|
Signaling by Receptor Tyrosine Kinases
|
524 |
0.435 |
|
36 |
|
p53 transcriptional gene network
|
95 |
0.435 |
|
37 |
|
Transcription Ligand-dependent activation of the ESR1/SP pathway
|
51 |
0.435 |
|
38 |
|
Validated transcriptional targets of deltaNp63 isoforms
|
47 |
0.435 |
|
39 |
|
Regulation of CFTR activity (norm and CF)
|
106 |
0.435 |
|
40 |
|
Diseases of glycosylation
|
249 |
0.435 |
|
41 |
|
Host-pathogen interaction of human coronaviruses - interferon induction
|
52 |
0.435 |
Genes names |
- Adenosine Deaminase RNA Specific
|
|
42 |
|
Validated transcriptional targets of TAp63 isoforms
|
54 |
0.435 |
|
43 |
|
Overview of interferons-mediated signaling pathway
|
168 |
0.435 |
Genes names |
- Adenosine Deaminase RNA Specific
|
|
44 |
|
Cytosolic sensors of pathogen-associated DNA
|
103 |
0.435 |
Genes names |
- Adenosine Deaminase RNA Specific
|
|
45 |
|
Translational Control
|
190 |
0.435 |
Genes names |
- Adenosine Deaminase RNA Specific
|
|
46 |
|
Methotrexate Pathway (Cancer Cell), Pharmacodynamics and Pharmacokinetics
|
34 |
0.435 |
|
47 |
|
Abacavir Pathway, Pharmacokinetics/Pharmacodynamics
|
13 |
0.435 |
|
48 |
|
Signaling by NTRKs
|
134 |
0.435 |
|
49 |
|
Cytokine Signaling in Immune system
|
732 |
0.435 |
Genes names |
- Adenosine Deaminase RNA Specific
|
|
50 |
|
Trans-sulfuration pathway
|
14 |
0.435 |
|
51 |
|
Phosphodiesterases in neuronal function
|
52 |
0.435 |
|
52 |
|
Thiopurine Pathway, Pharmacokinetics/Pharmacodynamics
|
33 |
0.435 |
|
53 |
|
Toll-like receptor signaling pathway
|
285 |
0.435 |
Genes names |
- Adenosine Deaminase RNA Specific
|
|
54 |
|
Interferon gamma signaling
|
203 |
0.435 |
Genes names |
- Adenosine Deaminase RNA Specific
|
|
55 |
|
Immune response Function of MEF2 in T lymphocytes
|
124 |
0.435 |
Genes names |
- Adenosine Monophosphate Deaminase 1
|
|
56 |
|
ADORA2B mediated anti-inflammatory cytokines production
|
419 |
0.435 |
|
57 |
|
1p36 copy number variation syndrome
|
88 |
0.435 |
Genes names |
- Methyltransferase 14, N6-Adenosine-Methyltransferase Subunit
|
|